Catalyst Wire Dossier Catalyst Wire Dossier

Second-generation trabecular micro-bypass stents

trabecular micro-bypass stents · Glaukos Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Second-generation trabecular micro-bypass stents, covering 2022-09-08 to 2022-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication [Phase 4]

See pricing